MetaCap

ImmunityBio (IBRX) News

NASDAQ: IBRXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

6.02-0.55 (-8.37%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

IBRX news summary

We found 46 recent headlines mentioning ImmunityBio (IBRX): 0 in the past week and 14 in the past 30 days, most often from Nasdaq, Seeking Alpha, Business Wire. IBRX is making an outsized move today, down 8.37% at $6.02, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "IBRX Q3 Earnings Miss, Anktiva Sales Decline Q/Q, Stock Down 18%", was published by Nasdaq on Nov 10, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest ImmunityBio headlines

Stocks mentioned alongside IBRX

Compare IBRX